A Comprehensive Map of FDA-Approved Pharmaceutical Products

This article was originally published by Hao Zhong, Ging Chan, Yuanjia Hu, Hao Hu and Defang Ouyang in Pharmaceutics 2018, 10(4), 263 under a Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Abstract :…
The po…


Ideation and implementation of an open science drug discovery business model – M4K Pharma

This paper was originally published by Maxwell Robert Morgan, Owen Gwilym Roberts, and Aled Morgan Edwards in Wellcome Open Res 2018, 3:154 under a Creative Commons Attribution License Abstract M4K…
The post Ideation and implementation of an open scien…


New tentative approval for Watson Labs drug dienogest; estradiol valerate

Dienogest; estradiol valerate is the generic ingredient in one branded drug marketed by Bayer Hlthcare and is included in one NDA. There are two patents protecting this compound. Drug patent…
The post New tentative approval for Watson Labs drug dienoge…


Most prolific drug patent challengers

This chart shows the generic pharmaceutical companies that had the most successful drug patent challenges from 2013 to 2018. Companies that successfully challenge patents on branded drugs are granted six…
The post Most prolific drug patent challengers …


New patent expiration for Chiesi Usa drug KENGREAL

Annual Drug Patent Expirations for KENGREAL Kengreal is a drug marketed by Chiesi Usa Inc and is included in one NDA. It is available from two suppliers. There are ten…
The post New patent expiration for Chiesi Usa drug KENGREAL appeared first on DrugP…


Obviousness-Type Double Patenting Just Became Less of a Problem for Innovators

This is a guest post from Pepper Hamilton Partners John P. Isacson and N. Nicole Stakleff. John can be contacted at [email protected] and Nicole can be contacted at [email protected] The Federal Circuit recently…
The post Obviousness-Type D…


A Review about Regulatory Status and Recent Patents of Pharmaceutical Co-Crystals

This article was originally published by Arun Kumar, Sandeep Kumar, and Arun Nanda in Adv Pharm Bull. 2018 Aug; 8(3): 355–363 under a Creative Commons License. Abstract Pharmaceutical Co-crystals are not new,…
The post A Review about Regulatory Status …


New patent expiration for APIL drug ACTONEL

Annual Drug Patent Expirations for ACTONEL Actonel is a drug marketed by Apil and Warner Chilcott and is included in two NDAs. It is available from four suppliers. There are…
The post New patent expiration for APIL drug ACTONEL appeared first on DrugPa…


New patent expiration for Sanofi Aventis drug OFORTA

Annual Drug Patent Expirations for OFORTA Oforta is a drug marketed by Sanofi Aventis Us and is included in one NDA. There are two patents protecting this drug. This drug…
The post New patent expiration for Sanofi Aventis drug OFORTA appeared first on …


New patent expiration for Warner Chilcott drug ACTONEL WITH CALCIUM (COPACKAGED)

Annual Drug Patent Expirations for ACTONEL+WITH+CALCIUM+%28COPACKAGED%29 Actonel With Calcium (copackaged) is a drug marketed by Warner Chilcott and is included in one NDA. There are five patents protecting this drug.…
The post New patent expiration fo…


Do NOT follow this link or you will be banned from the site!
%d bloggers like this: